학술논문
The story of the development of generic lenalidomide: How one company thwarted the Hatch-Waxman Act to generate billions of dollars in revenue
Document Type
Review Article
Author
Source
In Journal of Cancer Policy December 2023 38
Subject
Language
ISSN
2213-5383